Structure of a Major Antigenic Site on the Respiratory Syncytial Virus Fusion Glycoprotein in Complex with Neutralizing Antibody 101F - Wikidata - wikimedia - TriplyDB

Structure of a Major Antigenic Site on the Respiratory Syncytial Virus Fusion Glycoprotein in Complex with Neutralizing Antibody 101F

Structure of a Major Antigenic Site on the Respiratory Syncytial Virus Fusion Glycoprotein in Complex with Neutralizing Antibody 101F

http://www.wikidata.org/entity/Q27664797

about

Structural basis for immunization with postfusion respiratory syncytial virus fusion F glycoprotein (RSV F) to elicit high neutralizing antibody titers Structure of Respiratory Syncytial Virus Fusion Glycoprotein in the Postfusion Conformation Reveals Preservation of Neutralizing Epitopes Defining a protective epitope on factor H binding protein, a key meningococcal virulence factor and vaccine antigen Structure of RSV Fusion Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing Antibody Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus Analysis of Human RSV Immunity at the Molecular Level: Learning from the Past and Present Protein Crystallography in Vaccine Research and Development Max Bergmann lecture protein epitope mimetics in the age of structural vaccinology Characterization of neutralizing affinity-matured human respiratory syncytial virus F binding antibodies in the sub-picomolar affinity range.Structure and function of respiratory syncytial virus surface glycoproteins.A highly stable prefusion RSV F vaccine derived from structural analysis of the fusion mechanism Molecular characterization of circulating respiratory syncytial virus (RSV) genotypes in Gilgit Baltistan Province of Pakistan during 2011-2012 winter season A broadly neutralizing human monoclonal antibody exhibits in vivo efficacy against both human metapneumovirus and respiratory syncytial virus.Structure and immune recognition of trimeric pre-fusion HIV-1 Env.A study of the genetic variability of human respiratory syncytial virus (HRSV) in Cambodia reveals the existence of a new HRSV group B genotype.Characterization of hospital and community-acquired respiratory syncytial virus in children with severe lower respiratory tract infections in Ho Chi Minh City, Vietnam, 2010.Progress in understanding and controlling respiratory syncytial virus: still crazy after all these years Characterization of a Prefusion-Specific Antibody That Recognizes a Quaternary, Cleavage-Dependent Epitope on the RSV Fusion Glycoprotein Cholesterol-rich microdomains as docking platforms for respiratory syncytial virus in normal human bronchial epithelial cells Multiple B-cell epitope vaccine induces a Staphylococcus enterotoxin B-specific IgG1 protective response against MRSA infection Mechanism for pre-B cell loss in VH-mutant rabbits IBC's 22nd Annual Antibody Engineering and 9th Annual Antibody Therapeutics International Conferences and the 2011 Annual Meeting of The Antibody Society, December 5-8, 2011, San Diego, CA.Novel antigens for RSV vaccines.A Chimeric Pneumovirus Fusion Protein Carrying Neutralizing Epitopes of Both MPV and RSV Engineering, Structure and Immunogenicity of the Human Metapneumovirus F Protein in the Postfusion Conformation.Vaccines against respiratory syncytial virus: The time has finally come.Sendai virus as a backbone for vaccines against RSV and other human paramyxoviruses Rapid profiling of RSV antibody repertoires from the memory B cells of naturally infected adult donors Neutralizing epitopes on the respiratory syncytial virus fusion glycoprotein.Respiratory Syncytial Virus: The Influence of Serotype and Genotype Variability on Clinical Course of Infection.Trivalency of a Nanobody Specific for the Human Respiratory Syncytial Virus Fusion Glycoprotein Drastically Enhances Virus Neutralization and Impacts Escape Mutant Selection.Antiviral effect of cimicifugin from Cimicifuga foetida against human respiratory syncytial virus.Cimicifuga foetida L. inhibited human respiratory syncytial virus in HEp-2 and A549 cell lines.Sendai virus recombinant vaccine expressing a secreted, unconstrained respiratory syncytial virus fusion protein protects against RSV in cotton rats.Antibody-Induced Internalization of the Human Respiratory Syncytial Virus Fusion Protein.Functional correlations of respiratory syncytial virus proteins to intrinsic disorder.Contribution of Fcγ receptors to human respiratory syncytial virus pathogenesis and the impairment of T-cell activation by dendritic cells.Scop3D: three-dimensional visualization of sequence conservation.Cross-neutralization of four paramyxoviruses by a human monoclonal antibody.A study of the genetic variability of human respiratory syncytial virus in Croatia, 2006-2008.

P2860

Q27667876-A0B38EDE-AAC0-447B-800C-8706D492F456 Q27668015-9B0EDE9A-D4DF-4902-B2E8-FC7FFA8D4B51 Q27676318-18310A6E-5001-447B-BD38-66602313760E Q27677570-00B888FB-7DAE-4B0F-A7E8-1ED1DBF0C2AA Q27680499-58D39FA6-3819-4B20-B154-9C11C48652DE Q28080556-AB9B69DE-FBF2-4FEE-9A3B-9059081E289D Q28087528-46DCD8A6-F1C6-4DA8-AED8-5C81E3CEE759 Q30155145-30F73B70-599A-483B-BAB2-5A7AD83F8F38 Q34191108-362129BC-351C-40A3-9251-8968491851E1 Q34414405-FB658052-8EE1-4307-96CA-5398C90088A2 Q34492100-D4D96D2B-351B-4140-A583-EE2A6787A592 Q34994494-56AD18F7-2D75-4EFA-946D-A8F34E6B4A7A Q35127300-3B555C49-D0CB-4BCF-AF35-5B177A1539E7 Q35142291-7B602521-E8AD-431A-9E85-5B488DD03C3E Q35273655-3B778EF0-A94B-46F2-B40F-C1D450020553 Q35557357-F7A5FD5B-7523-4BA7-98D1-3D004D417947 Q35566601-C6A3D08F-6017-4537-9DC2-5E60BCA4EA9D Q35687662-A3A6A7E3-CE84-47DD-AA20-29365BFACF89 Q35689697-A1EA4BCC-E9C6-4C2F-AC77-975144F758AA Q35880774-4C994D02-955A-4E9A-BFA3-7C5C8138B195 Q35920333-DACA4F54-E69B-40C3-B3C1-A2B562F2ED75 Q35992493-A0FC8AFD-0EA0-4B45-9038-597BD099C72A Q36005960-A96F76D5-F1F4-4E42-83A3-E32CD740B70E Q36029158-F5AB509E-927F-4A68-819E-3FAFA7258504 Q36128048-E48FD522-1B34-4C71-9C7C-5EF2F0DF925C Q37018347-A756CB86-B8CC-465D-B691-2DBB1F2753F0 Q37118707-2531F86A-5C3F-4F33-BFBC-9251B88CEA47 Q37593886-14345C0F-BB65-415D-AC6A-2D131EF6B018 Q38394731-F7D9C89A-2D83-4A5B-83BE-914A406B2F61 Q38637248-FD9BC169-B833-4C52-B32F-5D36E378BBBC Q38750689-9FB132C1-D87E-493A-BBCB-ED41825DD7FA Q39289483-E372F230-28EC-48D2-868B-2263C2938C72 Q39402884-7866CBF0-A326-4A97-91CF-FEFF293FECA2 Q39868227-E106763A-E4A0-4090-9543-FDE9F49E1131 Q40216566-31755FE4-6019-41BD-AA76-7EEA58ADAC11 Q40721101-51C6642C-988F-496A-9D48-34F9FA9C1632 Q40959795-1FEF3E4D-A099-4763-A8F6-13059B707C8C Q42173061-AE2EA9C7-716E-47AD-9E34-B9F508B0EE9C Q42275949-64524BAA-83A7-4214-9D2E-EB4FCD82CC2E Q44288287-B6BD9A44-F20C-4162-B301-8A21ADEFA722

P2860

Structure of a Major Antigenic Site on the Respiratory Syncytial Virus Fusion Glycoprotein in Complex with Neutralizing Antibody 101F

http://www.wikidata.org/entity/Q27664797

description

2010 nî lūn-bûn

@nan

2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

name

Structure of a Major Antigenic ...... ith Neutralizing Antibody 101F

@ast

Structure of a Major Antigenic ...... ith Neutralizing Antibody 101F

@en

Structure of a Major Antigenic ...... ith Neutralizing Antibody 101F

@nl

type

label

Structure of a Major Antigenic ...... ith Neutralizing Antibody 101F

@ast

Structure of a Major Antigenic ...... ith Neutralizing Antibody 101F

@en

Structure of a Major Antigenic ...... ith Neutralizing Antibody 101F

@nl

prefLabel

Structure of a Major Antigenic ...... ith Neutralizing Antibody 101F

@ast

Structure of a Major Antigenic ...... ith Neutralizing Antibody 101F

@en

Structure of a Major Antigenic ...... ith Neutralizing Antibody 101F

@nl

P1433

Q27664797-3589752D-9828-4360-867C-B65987198E70

P1476

Q27664797-F353A93D-B789-4352-9923-572B9DAF46B9

P2093

Q27664797-008C47D8-FBA2-4588-88B4-CD4693778F0D

Q27664797-2C1A9E56-8625-4E35-BA3F-2DE1A32064A9

Q27664797-7DAEB8A4-E50C-4F4A-81FA-7E087FB11D1E

Q27664797-84E578F0-FE2F-497D-B4F9-A8826B9E9709

P2860

Q27664797-00F6664C-0B30-4C04-A3A7-B81F7BFD7F8C

Q27664797-11C15FC1-8F81-45C7-A557-0578F64669DF

Q27664797-195C515D-D71A-4D4F-B8A8-F02074380C37

Q27664797-19D03CED-053D-4C19-AE4E-DCEFCE3C1E8C

Q27664797-20857F5C-B919-4C1E-A4CB-BD9E8986C155

Q27664797-23205F72-ED96-470F-A420-DD6084326B82

Q27664797-2438A697-D0D7-4565-8B9E-EA0A36157C60

Q27664797-28B2C580-F177-4121-9F42-FE89A17988D2

Q27664797-379C7EE2-52B6-4891-BF81-B07B2D6A232A

Q27664797-3FE07587-522E-44FD-8535-2BB6D512FB86

P304

Q27664797-B474C196-D704-4A9F-AA24-A1B830DF32D7

P31

Q27664797-4AAF2C90-F4D5-467F-BF04-37B3CD5795BA

P3181

Q27664797-7A2761D1-B18C-4D62-ADAD-E9125293422D

P356

Q27664797-9C96C02C-468F-4FF8-A28E-8343A6BB4EAB

P433

Q27664797-96068ABD-957F-4A68-9052-29C9433A59BB

P478

Q27664797-F231FDBC-8811-4302-BBDB-2264ED483800

P50

Q27664797-2E101C44-10CE-464A-B8F2-B44A1C3D512E

Q27664797-30DC17C8-5A97-4CC3-A775-AD6DEE88F899

Q27664797-FBD18A2F-3225-42D1-8444-7EE0C75E1613

P577

Q27664797-8597D506-50AA-4558-B643-8D91FF1DFB94

P698

Q27664797-E0AE0A48-09B0-47F6-94C6-D97806232210

P921

Q27664797-1B916383-D73E-4326-98EA-5DA5774645B5

Q27664797-5F2E8037-C780-430A-BA72-8D9CC73E12D7

P932

Q27664797-50BC49A7-4CC6-4079-A3C3-AB93C6AAC365

P3181

P356

P1433

Journal of Virology

P1476

Structure of a major antigenic ...... ith neutralizing antibody 101F

@en

P2093

Jung-San Chang

http://www.w3.org/2001/XMLSchema#string

Man Chen

http://www.w3.org/2001/XMLSchema#string

Peter D Kwong

http://www.w3.org/2001/XMLSchema#string

Yongping Yang

http://www.w3.org/2001/XMLSchema#string

P2860

MolProbity: all-atom contacts and structure validation for proteins and nucleic acids

Neutralization epitopes of the F glycoprotein of respiratory syncytial virus: effect of mutation upon fusion function

Structure of Fab hGR-2 F6, a competitive antagonist of the glucagon receptor

The structure of the fusion glycoprotein of Newcastle disease virus suggests a novel paradigm for the molecular mechanism of membrane fusion

Crystal structure of the antigen-binding fragment of apoptosis-inducing mouse anti-human Fas monoclonal antibody HFE7A

Identification of a B-cell epitope of hyaluronidase, a major bee venom allergen, from its crystal structure in complex with a specific Fab

Structural basis of respiratory syncytial virus neutralization by motavizumab

Structure of the Newcastle disease virus F protein in the post-fusion conformation

Computational design of epitope-scaffolds allows induction of antibodies specific for a poorly immunogenic HIV vaccine epitope

Inference of macromolecular assemblies from crystalline state

P304

12236-12244

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1284987

http://www.w3.org/2001/XMLSchema#string

P356

10.1128/JVI.01579-10

http://www.w3.org/2001/XMLSchema#string

P433

23

http://www.w3.org/2001/XMLSchema#string

P478

84

http://www.w3.org/2001/XMLSchema#string

P50

Jason S McLellan

Barney S. Graham

P577

2010-09-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20881049

http://www.w3.org/2001/XMLSchema#string

P921

membrane fusion involved in viral entry into host cell

P932

2976384

http://www.w3.org/2001/XMLSchema#string